/PRNewswire/ According to a new report published by UnivDatos Markets Insights, the Bipolar Coagulator Market is expected to grow at a CAGR of around 6%.
A new study provides evidence for better functional recovery after endovascular therapy from a population of large-infarction strokes that could contribute to changing clinical practice.
The ENCHANTED2/MT trial, which was investigating intensive lowering of blood pressure in acute ischemic stroke patients after mechanical thrombectomy, has been stopped early due to safety concerns.